dievini Hopp BioTech holding GmbH & Co KG - 10 Dec 2025 SCHEDULE 13D/A Report for CUREVAC N.V. Common Shares, par value (euro)0.12 per share (CVAC)

Filing Manager
dievini Hopp BioTech holding GmbH & Co KG
Reporting Manager
dievini Hopp BioTech holding GmbH & Co. KG
Security
CUREVAC N.V. Common Shares, par value (euro)0.12 per share
Symbol
CVAC
Disclosed Ownership
0 shares
Ownership
0%
Form type
SCHEDULE 13D/A
Filing time
12 Dec 2025, 16:01:21 UTC
Date of event
10 Dec 2025
Previous filing
16 Jun 2025
SEC
View on sec.gov

Reporting Managers (9)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
dievini Hopp BioTech holding GmbH & Co. KG 0% 0 0 0 /s/ Dr. Christina Eschenfelder Dr. Christina Eschenfelder/Attorney-in-fact 0001696029
DH-LT-Investments GmbH 0% 0 0 0 /s/ Dr. Christina Eschenfelder Dr. Christina Eschenfelder/Attorney-in-fact
DH-Capital GmbH & Co. KG 0% 0 0 0 /s/ Dr. Christina Eschenfelder Dr. Christina Eschenfelder/Attorney-in-fact
OH Beteiligungen GmbH & Co. KG 0% 0 0 0 /s/ Dr. Christina Eschenfelder Dr. Christina Eschenfelder/Attorney-in-fact
Dietmar Hopp 0% 0 0 0 /s/ Dr. Christina Eschenfelder Dr. Christina Eschenfelder as attorney-in-fact
Oliver Hopp 0% 0 0 0 /s/ Dr. Christina Eschenfelder Dr. Christina Eschenfelder as attorney-in-fact
Daniel Hopp 0% 0 0 0 /s/ Dr. Christina Eschenfelder Dr. Christina Eschenfelder as attorney-in-fact
DHFS II Holding GmbH & Co. KG 0% 0 0 0 /s/ Dr. Christina Eschenfelder Dr. Christina Eschenfelder/Attorney-in-fact
Zweite DH Verwaltungs GmbH 0% 0 0 0 /s/ Dr. Christina Eschenfelder Dr. Christina Eschenfelder/Attorney-in-fact